EnerSyn Global (ESYN) vs McKesson (MCK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
McKesson (MCK) has outperformed EnerSyn Global (ESYN) over the past year, gaining 23.5% versus a loss of 26.5%. McKesson is the larger company by market cap ($123.47 billion vs $37.4 million), about 3298.2 times the size. McKesson pays a dividend yielding 0.32%, while EnerSyn Global does not currently pay one.
McKesson converts more of its revenue into profit, with a net margin of 1.2% versus -303.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ESYN | MCK |
|---|---|---|
| Share price | $1.11 | $1,069.43 |
| Market cap | $37.44M | $123.47B |
| 1-day change | -0.89% | +0.68% |
| YTD return | -25.50% | +30.37% |
| 1-year return | -26.49% | +23.49% |
| 5-year return | — | +382.57% |
| P/E ratio (TTM) | — | 27.58 |
| Forward P/E | — | 20.39 |
| EPS (TTM) | $-0.58 | $38.77 |
| Dividend yield | 0.00% | 0.32% |
| Annual dividend | $0.00 | $3.40 |
| Revenue (latest FY) | $866.93K | $403.43B |
| Revenue growth (YoY) | -30.84% | +12.36% |
| Net income (latest FY) | $-2.63M | $4.76B |
| Gross margin | 53.03% | 3.61% |
| Operating margin | — | 1.54% |
| Net margin | -303.44% | 1.18% |
| 52-week high | $2.81 | $1,121.50 |
| 52-week low | $0.88 | $723.68 |
| Distance from 52-week high | -60.50% | -4.64% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +8.57% |
| Average volume | 38.17K | 790.59K |
| Shares outstanding | 33.73M | 115.46M |
| Employees | 4 | 41,600 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- McKesson is about 3298.2 times larger than EnerSyn Global by market value ($123.47B vs $37.44M).
- MCK has outperformed ESYN by 50.0 percentage points over the past year.
- McKesson is more profitable, keeping 1.2 cents of every revenue dollar as net income versus -303.4 cents for EnerSyn Global.
- McKesson grew revenue faster in its latest fiscal year (+12.36% vs -30.84%).
About EnerSyn Global
ESYN stock →EnerSyn Global Inc. engages in the food and beverage business in Singapore and South Korea.
Health Care · Other Pharmaceuticals · 4 employees
About McKesson
MCK stock →McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Health Care · Other Pharmaceuticals · 41,600 employees
ESYN vs MCK FAQ
Which is bigger, EnerSyn Global or McKesson?
McKesson (MCK) is larger, with a market capitalization of $123.47B compared with $37.44M for EnerSyn Global (ESYN).
Which stock has performed better over the past year, ESYN or MCK?
MCK returned +23.49% over the past 12 months, compared with -26.49% for ESYN (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, EnerSyn Global or McKesson?
McKesson pays a dividend yielding 0.32%, while EnerSyn Global does not currently pay a regular dividend.
Are EnerSyn Global and McKesson in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.